Biopharmaceutical News and Research

RSS
Soligenix reports results from long-term stability studies of SGX204 anthrax vaccine

Soligenix reports results from long-term stability studies of SGX204 anthrax vaccine

19 Jan 2012
Stallergenes chooses Magic Software's iBOLT integration platform

Stallergenes chooses Magic Software's iBOLT integration platform

17 Jan 2012
CrystalGenomics raises KRW 3 billion in private placement

CrystalGenomics raises KRW 3 billion in private placement

13 Jan 2012
Sangart commences MP4CO Phase 1b study in sickle cell disease

Sangart commences MP4CO Phase 1b study in sickle cell disease

12 Jan 2012
Foundation Medicine, Sanofi enter strategic collaboration for cancer genome analysis

Foundation Medicine, Sanofi enter strategic collaboration for cancer genome analysis

11 Jan 2012
Shire, Janssen enter development and marketing agreement for Resolor

Shire, Janssen enter development and marketing agreement for Resolor

11 Jan 2012
Shire acquires rights to develop and market Resolor in the U.S.

Shire acquires rights to develop and market Resolor in the U.S.

10 Jan 2012
Telormedix raises 7.5 million CHF

Telormedix raises 7.5 million CHF

10 Jan 2012
Positive interim data from Idenix IDX184 12-week phase IIb trial on HCV

Positive interim data from Idenix IDX184 12-week phase IIb trial on HCV

9 Jan 2012
Idenix Pharmaceuticals makes progress with its HCV development pipeline

Idenix Pharmaceuticals makes progress with its HCV development pipeline

9 Jan 2012
miRagen, Silence partner to assess delivery potential of novel miRNA-based therapeutics

miRagen, Silence partner to assess delivery potential of novel miRNA-based therapeutics

9 Jan 2012
Bristol-Myers Squibb signs definitive agreement to acquire Inhibitex

Bristol-Myers Squibb signs definitive agreement to acquire Inhibitex

8 Jan 2012
Georgia Bio announces 2012 Deals of the Year for pharma, biopharma and medical device companies

Georgia Bio announces 2012 Deals of the Year for pharma, biopharma and medical device companies

From Medtronic 7 Jan 2012
New Zealand life science and health IT companies to showcase their products in San Francisco

New Zealand life science and health IT companies to showcase their products in San Francisco

7 Jan 2012
Lightlake intends to develop a treatment for premenstrual syndrome overeating

Lightlake intends to develop a treatment for premenstrual syndrome overeating

7 Jan 2012
Clearside Biomedical receives $4M venture capital investment

Clearside Biomedical receives $4M venture capital investment

6 Jan 2012
Two non-profit organizations to address critical shortage of funding for pediatric cancer research

Two non-profit organizations to address critical shortage of funding for pediatric cancer research

6 Jan 2012
AstraZeneca plans to progress Targacept's AZD1446 as treatment for AD

AstraZeneca plans to progress Targacept's AZD1446 as treatment for AD

5 Jan 2012
Ipsen, Oncodesign partner to discover and develop LRRK2 kinase inhibitors against PD

Ipsen, Oncodesign partner to discover and develop LRRK2 kinase inhibitors against PD

5 Jan 2012
NGP receives investment from Abbott to develop NGP 555 for AD

NGP receives investment from Abbott to develop NGP 555 for AD

5 Jan 2012

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback